在重症COVID-19-A回顾性研究中评估医院死亡风险的炎症生物标志物
Erika Bimbo-Szuhai1,2, Mihai Octavian Botea2,3, Dana Diana Romanescu2,4
1Department of Morphological Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Journal of personalized medicine
|May 25, 2024
概括
炎症标志物如C反应蛋白 (CRP),公素 (PCT) 和费里丁,以及高颗粒细胞/淋巴细胞 (G/L) 比率,预测严重的COVID-19患者的死亡率. 患有这些高标志物的老年肥胖患者面临更高的住院死亡风险.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 生物标志物和诊断方法
背景情况:
- 升高的白细胞 (WBC) 计数与COVID-19的严重程度相关,但缺乏对死亡率的预测能力.
- 识别早期预后指标对于在重症监护室 (ICU) 管理严重的COVID-19患者至关重要.
研究的目的:
- 为了研究炎症标志物对ICU住院COVID-19患者的疾病严重程度和死亡率的预后效用.
- 确定特定的生物标志物,可以快速分层高风险患者.
主要方法:
- 这是一项对209名在ICU中的COVID-19患者的回顾性观察性研究.
- 在第10和第14天评估C-反应蛋白 (CRP),前素 (PCT),粒细胞/淋巴细胞 (G/L) 比率,费里丁,年龄和肥胖.
- 分析了这些标志物对死亡率和疾病严重程度的预测值.
主要成果:
- 预测死亡率和严重程度的统计学显著差异观察到G/L比率 (p < 0.0001),PCT (p < 0.0002),CRP (p < 0.0001),费里丁 (p < 0.0001),年龄 (p < 0.0001) 和肥胖 (p < 0.0001).
- 一个G/L比率>20,升高的CRP,PCT和费里是显著的预测因素.
结论:
- 在接受ICU治疗的老年肥胖COVID-19患者中,高G/L比率,CRP,PCT和费里水平是住院死亡的重要风险因素.
- 这些炎症标志物可以帮助重症COVID-19病例的早期风险分层.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
138
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
138
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
Pneumonia III: Complications and Assessment
202
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
202


